Oneness Biotech Co (合一) yesterday said it expects revenue to increase next year assuming its ON101 ointment is approved.
Oneness, which has submitted an application for the treatment for diabetic foot ulcers to the Food and Drug Administration (FDA), said its phase 3 clinical trial showed that 62.2 percent of people who were treated with ON101 showed improvement.
Among those with an ulcer between 5cm2 and 10cm2, 62.2 percent healed after treatment with ON101, compared with 16.7 percent for Aquacel, a company filing with the Taipei Exchange said.
The FDA on Dec. 9 conducted a technical review of Oneness’ application and asked it to deliver administrative data last week, meaning it passed the review, the most challenging phase of the approval process, the company said.
“The business opportunity for ON101 is considerable, as there are 2.27 million people with diabetes in Taiwan,” Oneness founder William Lu (路孔明) told an investors’ conference. “Among them, at least 60,000 have diabetic foot ulcers, as the occurrence rate is 2.6 to 5.5 percent.”
A person with diabetic foot ulcers spends about NT$140,000 (US$4,911) on medicine per year, while 22,000 people have been hospitalized and 6,500 undergone an amputation, Lu said, citing National Health Insurance data, adding that the financial burden totals NT$10.8 billion per year.
“As ON101 has better efficacy, we expect its launch to reduce the hospitalization and amputation rates, and reduce the financial burden patients face,” he said.
“Diabetic foot ulcers are the complication that people with diabetes have to spend the most on,” he said.
A 15g tube of ON101 is likely to cost US$670, which would help Oneness gain a 25 to 30 percent share of the US market, he said.
People with an ulcer smaller than 2cm2 would need two tubes to completely heal, while those with ulcers between 5cm2 and 10cm2 would need seven tubes, Oneness said.
Those costs would be lower than current treatments, it said.
It expects sales to continue rising next year after it obtains approval to market the ointment, Lu said.
Oneness reported cumulative revenue of NT$39 million for the first 11 months of this year, up 229 percent year-on-year.
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors
RSS